Back
Organon & 10K Form
Sell
42
OGN
Organon &
Last Price:
$14.73
Seasonality Move:
1.77%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive OGN News And Ratings
See the #1 stock for the next 7 days that we like better than OGN
OGN Financial Statistics
Sales & Book Value
| Annual Sales: | $6.4B |
|---|---|
| Cash Flow: | $258M |
| Price / Cash Flow: | 6.76 |
| Annual Sales: | $1.83 |
| Price / Book: | 8.38 |
Profitability
| EPS (TTM): | 3.33000 |
|---|---|
| Net Income (TTM): | $864M |
| Gross Margin: | $3.7B |
| Return on Equity: | 397.42% |
| Return on Assets: | 6.97% |
Organon & Earnings Forecast
Key Organon & Financial Ratios
-
The Gross Profit Margin over the past 7 years for OGN is 58.02%.
-
The Selling, General & Administrative Expenses for OGN have been equal to 27.49% of Gross Profit Margin.
-
The Research & Development expenses have been 7.32% of Revenue.
-
The Interest Expense is 60.19% of Operating Income.
-
The Net Earning history of OGN is 13.49% of Total Revenues.
-
Per Share Earnings over the last 7 years have been positive in 2 years.
Organon & Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | OGN |
| Website: | organon.com |
Debt
| Debt-to-Equity Ratio: | 18.81 |
|---|---|
| Current Ratio: | 1.6 |
| Quick Ratio: | 0.75 |
Price-to-Earnings
| Trailing P/E Ratio: | 4.6 |
|---|---|
| Forward P/E Ratio: | 3.76 |